Related references
Note: Only part of the references are listed.Cancer stem cell targeting: Are we there yet?
Yuchae Jung et al.
ARCHIVES OF PHARMACAL RESEARCH (2015)
Pancreatic cancer stem cells: New insight into a stubborn disease
Han-xiang Zhan et al.
CANCER LETTERS (2015)
High serum CA 19-9 but not tumor size should select patients for staging laparoscopy in radiological resectable pancreas head and peri-ampullary cancer
N. Alexakis et al.
EJSO (2015)
Non-radical resection versus bypass procedure for pancreatic cancer - A consecutive series and systematic review
J. A. M. G. Tol et al.
EJSO (2015)
CD44 Regulates Pancreatic Cancer Invasion through MT1-MMP
Wei Jiang et al.
MOLECULAR CANCER RESEARCH (2015)
Hyaluronan-decorated polymer nanoparticles targeting the CD44 receptor for the combined photo/chemo-therapy of cancer
Sara Maiolino et al.
NANOSCALE (2015)
Systematic review of innovative ablative therapies for the treatment of locally advanced pancreatic cancer
S. J. E. Rombouts et al.
BRITISH JOURNAL OF SURGERY (2015)
Prognostic Value of CD44 Variant exon 6 Expression in Non-Small Cell Lung Cancer: a Meta-analysis
Shuang Zhao et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)
DNA-PKcs is important for Akt activation and gemcitabine resistance in PANC-1 pancreatic cancer cells
Hu Hao et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
Inversed relationship between CD44 variant and c-Myc due to oxidative stress-induced canonical Wnt activation
Go J. Yoshida et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
The prognostic value of CD44 expression in gastric cancer: A meta-Analysis
Yansu Chen et al.
BIOMEDICINE & PHARMACOTHERAPY (2014)
CD44v/CD44s expression patterns are associated with the survival of pancreatic carcinoma patients
Zhonghu Li et al.
DIAGNOSTIC PATHOLOGY (2014)
Antibody Against CD44s Inhibits Pancreatic Tumor Initiation and Postradiation Recurrence in Mice
Ling Li et al.
GASTROENTEROLOGY (2014)
Pancreatic tumour formation and recurrence after radiotherapy are blocked by targeting CD44
Natalie J. Wood
Nature Reviews Gastroenterology & Hepatology (2014)
CD24 and S100A4 Expression in Resectable Pancreatic Cancers With Earlier Disease Recurrence and Poor Survival
Sang Hyub Lee et al.
PANCREAS (2014)
Predictors for resectability and survival in locally advanced pancreatic cancer after gemcitabine-based neoadjuvant therapy
Ying-Jui Chao et al.
BMC SURGERY (2014)
Pancreatectomy for adenocarcinoma in elderly patients: Postoperative outcomes and long term results A study of the French Surgical Association
O. Turrini et al.
EJSO (2013)
Pathologic staging of pancreatic, ampullary, biliary, and gallbladder cancers: pitfalls and practical limitations of the current AJCC/UICC TNM staging system and opportunities for improvement
N. Volkan Adsay et al.
SEMINARS IN DIAGNOSTIC PATHOLOGY (2012)
CD44, a therapeutic target for metastasising tumours
Veronique Orian-Rousseau
EUROPEAN JOURNAL OF CANCER (2010)
Share Paper
